$1.71
-0.03-1.72%
Pre-Market: 7:41 PM EDT
15 minutes delayed
Cyclacel Pharmaceuticals
CYCCNASDAQ
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Stock, Earnings Estimates, EPS, And Revenue
Cyclacel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 7
EPS Estimate
$-1.430
Quarterly Revenue Estimate
$30K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$449K
Analyze the earnings history of Cyclacel Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals | -$6.60 | -$1.43 | — | — | $373.00K | $30.00K | — | — | 08/07/2024 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$7.05 | -$4.74 | -$2.27 | 52.11% | $0.00 | — | $29.00K | — | 05/14/2024 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$9.00 | -$5.89 | -$6.23 | -5.77% | $0.00 | — | $31.00K | — | 03/19/2024 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$6.30 | -$5.40 | -$7.35 | -36.11% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$6.90 | -$7.50 | -$6.60 | 12.00% | $0.00 | — | $373.00K | — | 08/09/2023 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$6.30 | -$9.90 | -$7.05 | 28.79% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$8.10 | -$7.20 | -$9.00 | -25.00% | $0.00 | — | $0.00 | — | 03/06/2023 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$8.10 | -$8.40 | -$6.30 | 25.00% | $0.00 | — | $0.00 | — | 11/09/2022 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$8.40 | -$8.25 | -$6.90 | 16.36% | $0.00 | — | $0.00 | — | 08/10/2022 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$7.50 | -$10.20 | -$6.30 | 38.24% | $0.00 | — | $0.00 | — | 05/11/2022 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$20.10 | -$9.75 | -$8.10 | 16.92% | $0.00 | — | $0.00 | — | 03/28/2022 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$7.05 | -$9.75 | -$8.10 | 16.92% | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$8.70 | -$7.50 | -$8.40 | -12.00% | $0.00 | — | $0.00 | — | 08/11/2021 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$22.20 | -$7.35 | -$7.50 | -2.04% | $0.00 | — | $0.00 | — | 05/12/2021 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$42.00 | -$7.65 | -$20.10 | -162.75% | $0.00 | — | $0.00 | — | 02/25/2021 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$33.00 | -$8.25 | -$7.05 | 14.55% | $0.00 | — | $0.00 | — | 11/11/2020 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$33.00 | -$7.05 | -$8.70 | -23.40% | $0.00 | — | $0.00 | — | 08/12/2020 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$42.00 | -$43.50 | -$22.20 | 48.97% | $0.00 | — | $0.00 | — | 05/12/2020 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$51.00 | -$39.00 | -$42.00 | -7.69% | $150.00K | — | $0.00 | — | 02/26/2020 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$54.00 | -$48.00 | -$33.00 | 31.25% | $0.00 | — | $0.00 | — | 11/13/2019 | Get Alert |
| CYCC | Cyclacel Pharmaceuticals | -$48.00 | — | -$33.00 | — | $0.00 | — | $0.00 | — | 08/13/2019 | Get Alert |
Cyclacel Pharmaceuticals (CYCC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $-2.27 | $-4.74 | 52.1 % |
| Dec 2023 | 2024-03-19 | $-6.23 | $-5.89 | -5.77 % |
| Sep 2023 | 2023-11-13 | $-7.35 | $-5.40 | -36.1 % |
| Jun 2023 | 2023-08-09 | $-6.60 | $-7.50 | 12.0 % |
Cyclacel Pharmaceuticals (CYCC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Cyclacel Pharmaceuticals (NASDAQ:CYCC) reporting earnings?
Cyclacel Pharmaceuticals (CYCC) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Cyclacel Pharmaceuticals (NASDAQ:CYCC)?
The Actual EPS was $-2.27, which beat the estimate of $-4.74.
What were Cyclacel Pharmaceuticals’s (NASDAQ:CYCC) revenues?
The Actual Revenue was $29K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.